ABL proto-oncogene 1, non-receptor tyrosine kinase
Senast uppdaterad 3 Mar 2023
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ask Patient
- Ljudversion
- Lägg till i föredragna källor på Google
Den ABL1 gene provides instructions for making a protein involved in many processes in cells throughout the body. The ABL1 protein functions as a kinase, which is an enzyme that changes the activity of other proteins by adding a cluster of oxygen and phosphorus atoms (a phosphate group) at specific positions. The ABL1 kinase is normally turned off (inactive) and must be turned on (activated) to perform its functions.
Videoval för GenesVideobibliotek
Normal function
Den ABL1 gene provides instructions for making a protein involved in many processes in cells throughout the body. The ABL1 protein functions as a kinase, which is an enzyme that changes the activity of other proteins by adding a cluster of oxygen and phosphorus atoms (a phosphate group) at specific positions. The ABL1 kinase is normally turned off (inactive) and must be turned on (activated) to perform its functions.
The ABL1 kinase can be turned on by a number of different triggers and can add a phosphate group to many different proteins (also called substrates). This diversity allows ABL1 to be involved in a wide variety of cellular processes, including cell growth and division (proliferation), maturation (differentiation), and movement (migration). It can either aid in cell survival or trigger controlled cell death (apoptosis), depending on cellular conditions. The ABL1 kinase interacts with several proteins involved in the network of fibers called the actin cytoskeleton, which makes up the structural framework inside cells. These interactions help control cell migration and the attachment of cells to one another (adhesion), among many other processes. ABL1 can also help regulate the activity of other genes.
Den ABL1 gene belongs to a class of genes known as oncogenes. When mutated, oncogenes have the potential to cause normal cells to become cancerous.
Conditions referring to this gene or chromosome
Other names
Abelson tyrosine-protein kinase 1
ABL
bcr/abl
bcr/c-abl oncogene protein
c-ABL
c-abl oncogene 1, receptor tyrosine kinase
c-ABL1
JTK7
p150
proto-oncogene c-Abl
proto-oncogene tyrosine-protein kinase ABL1
tyrosine-protein kinase ABL1 isoform a
tyrosine-protein kinase ABL1 isoform b
v-abl
v-abl Abelson murine leukemia viral oncogene homolog 1
Related patient information and medicines

Patient information leaflet
Kronisk myeloisk leukemi
Chronic myeloid leukaemia (CML) is sometimes called chronic myelogenous leukaemia, chronic granulocytic leukaemia, or chronic myelocytic leukaemia. What is chronic myeloi... An abnormal gene called BCR-ABL is made on the abnormal chromosome 22. This medicine is known as a tyrosine kinase inhibitor. The chemical tyrosine kinase is made by the.

Patient information leaflet
Muncancer
Dia... Dr Krishna Vakharia , 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or ruling out of cancer within 28 days of being referred urgently by their GP for suspected cancer. To confirm the diagnosis It is likely that you will need a biopsy. Cetuximab is an.

Patient information leaflet
Mastocytos och mastcellssjukdomar
A mast cell is a type of white blood cell. If the condition is severe, surgery to remove the spleen (splenectomy), medicines that have an effect on the immune system (suc... Dr Sarah Jarvis , 28th September 2021 Midostaurin for treating advanced systemic mastocytosis The National Institute for Health and Care Excellence (NICE) has brought out new.

Patient information leaflet
Leverfunktionstester
Leverfunktionstester are a set of blodprov commonly done to check on the health of your liver. Changes in liver function tests give a clue as to whether your liver is under strain, inflamed, infected or diseased, and how badly. The pattern of the liver function tests can give a clue to the cause and can allow early detection of unsuspected.

Patient information leaflet
Familjär hyperkolesterolemi
It is a condition where you have a very high cholesterol level in your blood. Too much cholesterol in your blood causes cholesterol deposits in your arteries and so an increased risk of early heart disease Heart disease (coronary heart disease), stroke Stroke and peripheral artery disease Peripheral arterial disease. To find out more about the.

Patient information leaflet
Myasthenia gravis
Myasthenia gravis (MG) is a condition where muscles become easily tired och weak. It is due to a problem with how the nerves stimulate the muscles to tighten (contract). The muscles around the eyes are commonly affected first. Treatment is usually effective. However, relapses are common and many people with myasthenia gravis have long-term.
Vidare läsning och referenser
- ABL proto-oncogene 1, non-receptor tyrosine kinase; MedlinePlus, National Library of Medicine.
- Chereda B, Melo JV. Natural course and biology of CML. Ann Hematol. 2015 Apr;94 Suppl 2:S107-21. doi: 10.1007/s00277-015-2325-z. Epub 2015 Mar 27.
- Colicelli J. ABL tyrosine kinases: evolution of function, regulation, and specificity. Sci Signal. 2010 Sep 14;3(139):re6. doi: 10.1126/scisignal.3139re6.
- De Braekeleer E, Douet-Guilbert N, Rowe D, Bown N, Morel F, Berthou C, Ferec C, De Braekeleer M. ABL1 fusion genes in hematological malignancies: a review. Eur J Haematol. 2011 May;86(5):361-71. doi: 10.1111/j.1600-0609.2011.01586.x. Epub 2011 Mar 23.
- Laneuville P. Abl tyrosine protein kinase. Semin Immunol. 1995 Aug;7(4):255-66. doi: 10.1006/smim.1995.0030.
- Lugo TG, Pendergast AM, Muller AJ, Witte ON. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science. 1990 Mar 2;247(4946):1079-82. doi: 10.1126/science.2408149.
- Wang JY. The capable ABL: what is its biological function? Mol Cell Biol. 2014 Apr;34(7):1188-97. doi: 10.1128/MCB.01454-13. Epub 2014 Jan 13.
Artikelhistorik
Artikeln finns också på Engelska, Tyska, Spanska, Franska, Italienska, Portugisiska, Hindi, Hebreiska, Arabiska, och Svenska.
3 Mar 2023 | Senaste versionen
1 Sept 2016 | Ursprungligen publicerad
Dela dina tankar eller erfarenheter med andra i vår patientgemenskaper.
Anmäl dig till Patientens nyhetsbrev
Din veckovisa dos av tydliga, pålitliga hälsoråd - skrivna för att hjälpa dig känna dig informerad, självsäker och i kontroll.
Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.

